Literature DB >> 1372986

sar: a genetic mouse model for human sarcosinemia generated by ethylnitrosourea mutagenesis.

C O Harding1, P Williams, D M Pflanzer, R E Colwell, P W Lyne, J A Wolff.   

Abstract

A mouse mutant with sarcosinemia was found by screening the progeny of ethylnitrosourea-mutagenized mice for aminoacidurias. Paper chromatography, column chromatography, and gas chromatography-mass spectrometry identified high levels of sarcosine in the urine of the mutant mice. While sarcosine cannot be detected in the urine of plasma of normal mice, the urinary sarcosine level of 102 +/- 58 mmol per g of creatinine in the mutant mice was at the upper range of the urinary levels (1.5-4.5 mmol of sarcosine per g of creatinine) observed in humans with sarcosinemia. Similarly, the plasma sarcosine level of 785 +/- 153 mumol/liter in the sarcosinemic mice was at the upper range of the plasma sarcosine levels (53-760 mumol/liter) observed in affected humans. Sarcosine dehydrogenase [sarcosine:(acceptor) oxidoreductase (demethylating), EC 1.5.99.1] activity was deficient in sarcosinemic mice. The sarcosinuria phenotype in these mice was inherited as an autosomal recessive trait. This mouse mutant provides a useful genetic model for human sarcosinemia and for development of therapeutic approaches for genetic disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372986      PMCID: PMC48718          DOI: 10.1073/pnas.89.7.2644

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  THE OXIDATION OF N-METHYLGLYCINES BY PRIMATE LIVER MITOCHONDRIA. ASSAY, PURIFICATION, AND CHARACTERIZATION OF SARCOSINE DEHYDROGENASE.

Authors:  D D HOSKINS; R A BJUR
Journal:  J Biol Chem       Date:  1964-06       Impact factor: 5.157

Review 2.  Development and applications of a molecular genetic linkage map of the mouse genome.

Authors:  N G Copeland; N A Jenkins
Journal:  Trends Genet       Date:  1991-04       Impact factor: 11.639

3.  Hypersarcosinemia with craniostenosis-syndactylism syndrome.

Authors:  R Minami; K Olek; P Wardenbach
Journal:  Humangenetik       Date:  1975-06-19

4.  Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.

Authors:  V M Chapman; D R Miller; D Armstrong; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Mapping to molecular resolution in the T to H-2 region of the mouse genome with a nested set of meiotic recombinants.

Authors:  T R King; W F Dove; B Herrmann; A R Moser; A Shedlovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.

Authors:  M R Kuehn; A Bradley; E J Robertson; M J Evans
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

7.  Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis.

Authors:  G Hoffmann; S Aramaki; E Blum-Hoffmann; W L Nyhan; L Sweetman
Journal:  Clin Chem       Date:  1989-04       Impact factor: 8.327

Review 8.  The new mouse genetics: altering the genome by gene targeting.

Authors:  M R Capecchi
Journal:  Trends Genet       Date:  1989-03       Impact factor: 11.639

9.  Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase.

Authors:  J D McDonald; V C Bode; W F Dove; A Shedlovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine.

Authors:  B Lemieux; C Auray-Blais; R Giguère; D Shapcott; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more
  3 in total

1.  Probabilistic analysis of recessive mutagenesis screen strategies.

Authors:  Jeremy D Silver; Douglas J Hilton; Melanie Bahlo; Benjamin T Kile
Journal:  Mamm Genome       Date:  2007-01-23       Impact factor: 2.957

2.  Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia.

Authors:  Ifat Bar-joseph; Elon Pras; Haike Reznik-Wolf; Dina Marek-Yagel; Almogit Abu-Horvitz; Maya Dushnitzky; Nurit Goldstein; Shlomit Rienstein; Michal Dekel; Ben Pode-Shakked; Joseph Zlotnik; Anelia Benarrosh; Philippe Gillery; Niklaus Hofliger; Christiane Auray-Blais; Roselyne Garnotel; Yair Anikster
Journal:  Hum Genet       Date:  2012-07-24       Impact factor: 4.132

3.  Chemically induced acute model of sarcosinemia in wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2015-11-12       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.